Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes

Journal of Clinical Investigation

Volumn 104, Issue 8, 1999, Pages 1139-1147

  Janoff, Edward N ^a,c   Fasching, Claudine ^a   Orenstein, Jan M ^b   Rubins, Jeffrey B ^a   Opstad, Nancy L ^a   Dalmasso, Agustin P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; IMMUNOGLOBULIN A;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFECTION RESISTANCE; MALE; NORMAL HUMAN; PHAGOCYTE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0032720303     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6310     Document Type: Article

References (71)

1. Svanborg-Eden, C., and Svennerholm, A.-M. 1978. Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infect. Immun. 22:790-797.
2. Russell, M.W., Kilian, M., and Lamm, M.E. 1999. Biological activities of IgA. In Mucosal immunology. 2nd edition. P.L. Ogra et al., editors. Academic Press. San Diego, CA. 225-240.
3. Underdown, B.J., and Schiff, J.M. 1986. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu. Rev. Immunol. 4:389-417.
4. Kilian, M., Mestecky, J., and Russell, M.W. 1988. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 52:296-303.
5. Mestecky, J., and McGhee, J.R. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. In Advances in immunology. Volume 40. F.J. Dixon, editor. Academic Press.San Diego, CA. 153-245.
6. McGhee, J.R., et al. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 10:75-88.
7. Johnson, S., Gerding, D.N., and Janoff, E.N. 1992. Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile (CD) infection. J. Infect. Dis. 166:1287-1294.
8. Johnson, S., Sypura, W.D., Gerding, D.N., Ewing, S., and Janoff, E.N. 1995. Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease. Infect. Immun. 63:3166-3173.
9. Kerr, M.A. 1990. The structure and function of human IgA. Biochem. J. 271:285-296.
10. Mazanec, M.B., Kaetzel, C.S., Lamm, M.E., Fletcher, D., and Nedrud, J.G. 1992. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA. 89:6901-6905.
11. Kaetzel, C.S., Robinson, J.K., Chintalacharuvu, K.R., Vaerman, J.-P., and Lamm, M.E. 1991. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: A local defense function for IgA. Proc. Natl. Acad. Sci. USA. 88:8796-8800.
12. Russell, M.W., Reinholdt, J., and Kilian, M. 1989. Anti-inflammatory activity of human IgA antibodies and their Fabα fragments: inhibition of IgG-mediated complement activation. Eur. J. Immunol. 19:2243-2249.
13. Jarvis, G.A., and Griffiss, J.M. 1991. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of Fab binding to the polysaccharide capsule. J. Immunol. 147:1962-1967.
14. Carson, P.J., Schut, R.L., Simpson, M.L., O'Brien, J., and Janoff, E.N. 1995. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J. Infect. Dis. 172:340-345.
15. Johnson, S., Opstad, N.L., Douglas, J.M., Jr., and Janoff, E.N. 1996. Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides. Infect. Immun. 64:4339-4344.
16. Tuomanen, E.I., Austrian, R., and Masure, H.R. 1995. Pathogenesis of pneumococcal infection. N. Engl. J. Med. 332:1280-1284.
17. Musher, D.M., et al. 1992. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin. Infect. Dis. 17:66-73.
18. Bennett, N.M., Buffington, J., and La Force, F.M. 1992. Pneumococcal bacteremia in Monroe County, New York. Am. J. Public Health. 82:1513-1516.
19. Austrian, R., and Gold, J. 1964. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med. 60:759-776.
20. Lue, C., Tarkowski, A., and Mestecky, J. 1988. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J. Immunol. 140:3793-3800.
21. Tarkowski, A., et al. 1990. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J. Immunol. 144:3770-3778.
22. Opstad, N.L., et al. 1995. Impact of Streptococcus pneumoniae bacteremia and human immunodeficiency virus type 1 on oral mucosal immunity. J. Infect. Dis. 172:567-571.
23. Weiss, P.J., Wallace, M.R., Oldfield, E.C., III, O'Brien, J., and Janoff, E.N. 1995. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influence type b conjugate vaccine. J. Infect. Dis. 171:1217-1222.
24. Friguet, B., Chaffotte, A.F., Djavadi-Ohaniance, L., and Goldberg, M.E. 1985. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods. 77:305-319.
25. Janoff, E.N., Hardy, W.D., Smith, P.D., and Wahl, S.M. 1991. Levels, specificity, and affinity of IgG specific for recall antigens in patients with HIV. J. Immunol. 147:2130-2135.
26. Kutteh, W.H., Koopman, W.J., Conley, M.E., Egan, M.L., and Mestecky, J. 1980. Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens. J. Exp. Med. 152:1424-1429.
27. Schrohenloher, R.E., Kunkel, H.G., and Tomasi, T.B. 1964. Activity of dissociated and reassociated 19S anti-globulins. J. Exp. Med. 120:1215-1229.
28. Negro Ponzi, A., Merlino, C., Angeretti, A., and Penna, R. 1985. Virus-specific polymeric immunoglobulin A antibodies in serum from patients with rubella, measles, varicella, and herpes zoster virus infections. J. Clin. Microbiol. 22:505-509.
29. Gray, B.M. 1990. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae capsular polysaccharides. Infect. Immun. 85:694-697.
30. Romero-Sceiner, S., et al. 1997. Standardization of an opsonophagocytic assay for the measurement of functional activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
31. Janoff, E.N., Fasching, C., Ojoo, J.C., O'Brien, J., and Gilks, C.F. 1997. Responsiveness of HIV-1-infected Kenyan women with and without pneumococcal disease to pneumococcal vaccine. J. Infect. Dis. 175:975-978.
32. Skubitz, K.M., Zhen, Y., and August, J.T. 1984. Dexamethasone synergistically induces chemotactic peptide receptor expression in HL-60 cells. Blood. 59:586-593.
33. Platt-Mills, T.A.E., and Ishizaka, K. 1974. Activation of the alternative pathway of human complement by rabbit cells. J. Immunol. 113:348-358.
34. Polotsky, Y., Nataro, J.P., Kotler, D., Barrett, T.J., and Orenstein, J.M. 1997. HEp-2 cell adherence patterns, serotyping, and DNA analysis of Escherichia coli isolates from eight patients with AIDS and chronic diarrhea. J. Clin. Microbiol. 35:1952-1958.
35. Heilmann, C., Barington, T., and Sigsgaard, T. 1988. Subclass of individual IgA-secreting human lymphocytes. Investigation of in vivo pneumococcal polysaccharide-induced and in vitro mitogen-induced blood B cells by monolayer plaque-forming cell assays. J. Immunol. 140:1496-1499.
36. Payne, N.R., Concepcion, N.F., and Anthony, B.F. 1990. Opsonic effect of jacalin and human immunoglobulin A on type II group B stretotocci. Infect. Immun. 58:3663-3670.
37. Russell, G.J., Gotschlich, E.C., and Blake, M.S. 1984. A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen. J. Exp. Med. 160:1467-1475.
38. Heden, L.O., Frithz, E., and Lindahl, G. 1991. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur. J. Immunol. 21:1481-1490.
39. Hammerschmidt, S., Talay, S.R., Brandtzaeg, P., and Chhatwal, G.S. 1997. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25:1113-1124.
40. Rosenow, C., et al. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25:819-829.
41. Bessen, D., and Fischetti, V.A. 1988. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J. Exp. Med. 167:1945-1950.
42. Steinitz, M., Tamir, S., Ferne, M., and Goldfarb, A. 1986. A protective human monoclonal IgA antibody produced in vitro: anti-pneumococcal antibody engendered by Epstein-Barr virus-immortalized cell line. Eur. J. Immunol. 16:187-193.
43. Hiemstra, P.S., Gorter, A., Stuurman, M.E., van Es, L.A., and Daha, M.R. 1987. Activation of the alternative pathway of complement by human serum IgA. Eur. J. Immunol. 17:321-326.
44. Schaapherder, A.F.M., Gooszen, H.G., te Bulte, M.-T.J.W., and Daha, M.R. 1995. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies. Transplantation. 60:287-291.
45. Valim, Y.M.L., and Lachmann, P.J. 1991. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin. Exp. Immunol. 84:1-8.
46. Renegar, K.B., Jackson, G.D.F., and Mestecky, J. 1998. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J. Immunol. 160:1219-1223.
47. Taylor, H.P., and Dimmock, N.J. 1985. Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG. J. Exp. Med. 161:198-209.
48. Duncan, A.R., and Winter, G. 1998. The binding site for C1q on IgG. Nature. 332:738-740.
49. 414 and the secretory tailpiece. J. Immunol. 162:3448-3455.
50. Hostetter, M.K., Krueger, R.A., and Schmeling, D.J. 1984. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement. J. Infect. Dis. 150:653-661.
51. Hostetter, M.K. 1986. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J. Infect. Dis. 153:682-693.
52. Reynolds, H.Y. 1987. Bronchoalveolar lavage. Am. Rev. Respir. Dis. 135:250-263.
53. Kaplan, M.E., Dalmasso, A.P., and Woodson, M. 1972. Complement-dependent opsonization of incompatible erythrocytes by human secretory IgA. J. Immunol. 108:275-278.
54. Hiemstra, P.S., et al. 1988. Activation of complement by serum IgA, secretory IgA, and IgA1 fragments. Mol. Immunol. 25:527-533.
55. Russell, M.W., and Mansa, B. 1989. Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound. Scand. J. Immunol. 30:175-183.
56. Zhang, W., and Lachman, P.J. 1994. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes. Immunology. 81:137-141.
57. Miletic, V.D., and Frank, M.M. 1995. Complement-immunoglobulin interactions. Curr. Opin. Immunol. 7:41-47.
58. Lappin, D.F., Birnie, G.D., and Whaley, K. 1990. Interferon-mediated transcriptional and post-transcriptional modulation of complement gene expression in human monocytes. Eur. J. Biochem. 194:177-184.
59. Hetland, G., Johnson, E., Falk, R.J., and Eskeland, T. 1986. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex. Scand. J. Immunol. 24:421-428.
60. Einstein, L.P., Schneeberger, E.E., and Colten, H.R. 1976. Synthesis of the second component of complement by long-term primary cultures of human monocytes. J. Exp. Med. 143:114-126.
61. Whaley, K. 1980. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J. Exp. Med. 151:501-516.
62. Cole, F.S., Matthews, W.J., Jr., Marino, J.T., Gash, D.J., and Colton, H.R. 1980. Control of complement synthesis and secretion in bronchoalveolar and peritoneal macrophages. J. Immunol. 125:1120-1124.
63. Andoh, A., Fujiyama, Y., Bamba, T., and Hosoda, S. 1993. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J. Immunol. 151:4239-4247.
64. Rothman, B.L., Despins, A.W., and Kreutzer, D.L. 1990. Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line, A549. J. Immunol. 145:592-598.
65. Botto, M., Lissandrini, D., Sorio, C., and Walport, M.J. 1992. Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J. Immunol. 149:1348-1355.
66. Nikolova, E.B., and Russell, M.W. 1995. Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells. J. Leukoc. Biol. 57:875-882.
67. Hostoffer, R.W., Krukovets, I., and Berger, M. 1994. Enhancement by tumor necrosis factor-α of Fcα receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes. J. Infect. Dis. 170:82-87.
68. Bobak, D.A., Gaither, T.A., Frank, M.M., and Tenner, A.J. 1987. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138:1150-1156.
69. Klebanoff, S.J., et al. 1986. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136:4220-4229.
70. Weisbart, R.H., Kacena, A., Schuh, A., and Golde, D.W. 1988. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature. 332:647-648.
71. Hostoffer, R.W., Krukovets, I., and Berger, M. 1993. Increased FcαR expression and IgA-mediated function on neutrophils induced by chemoattractants. J. Immunol. 150:4532-4540.